-
St Johns Wort and Drug Interactions; Serum Potassium and Stroke Risk Among Hypertensive Adults; Skin Cancer Prevention and Detection Practices Among Siblings of Patients with Melanoma
-
-
To improve patient survival, the emergency physician (EP) must be knowledgeable about current concepts and controversies in the management of patients in shock. No longer can one simply rely on the presence of traditional clinical markers of shock to make the diagnosis. New and innovative monitoring techniques, as well as continually evolving treatment algorithms, are at the forefront of shock research. This article will educate and update the EP on current and future trends in the management of patients in shock. Equipped with this information, the EP more effectively can identify patients in shock, administer the latest evidence-based treatment, and ultimately improve patient outcome.
-
-
A high saturated-fat and no-starch diet resulted in modest weight loss without negative effects on serum lipid levels; weight loss can be continued for up to a year with such a diet.
-
A consensus panel updates recent understanding about the causes and treatment in common neuropathic pain problems.
-
The study found that high-intensity warfarin therapy was not necessary for the prevention of recurrent thrombosis in the APA syndrome.
-
A majority of gastric fundic polyps are benign. Their presence in unscreened individuals older than 50 might warrant colonoscopy.
-
The FDA has approved tadalafil, the third phosphodiesterase type 5 inhibitor (PDE5) for the treatment of erectile dysfunction.
-
Two injectable biologic therapies, etanercept and efalizumab, have been shown to be highly effective in treating psoriasis. Etanercept has been used in rheumatoid arthritis since 1998, and efalizumab is a new agent in phase III trials. Psoriasis is a debilitating autoimmune illness, and these new therapies, while expensive, will be a welcome addition for patients suffering from a severe form of this disease.
